DB18549InvestigationalCell transplant therapies
ASP-7317 consists of human embryonic stem cell-derived retinal pigment epithelium cells.
- Also known as
- ACT hESC-RPE · hESC-derived RPE · hRPE cell therapy · MA09-hRPE
- Code names
- ASP-7317
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of ASP-7317, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account